Search clinical trials for: ASP1570
Total 61 results
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP1585United States
-
Ganymed Pharmaceuticals GmbHCompletedOvarian CancerBelgium, Germany
-
Astellas Pharma IncFibroGenCompletedChronic Kidney DiseaseJapan
-
Astellas Pharma IncFibroGenCompletedESA-naive Hemodialysis Chronic Kidney Disease Patients With AnemiaJapan
-
Astellas Pharma IncFibroGenCompletedPeritoneal Dialysis Chronic Kidney Disease Patients With AnemiaJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncFibroGenCompleted
-
Astellas Pharma IncCompletedAnemia in Chronic Kidney Disease Patients Not on DialysisJapan
-
Astellas Pharma Global Development, Inc.FibroGenCompletedHealthy Adult SubjectsGermany
-
Astellas Pharma IncCompletedAnemia | Hemodialysis | Renal ImpairmentJapan
-
Astellas Pharma IncFibroGenCompletedHemodialysis Patients With Renal AnemiaJapan
-
Astellas Pharma Europe B.V.CompletedHealthy SubjectsUnited Kingdom
-
Astellas Pharma Europe B.V.FibroGenCompletedImpaired Renal Function | Normal Renal FunctionGermany, United Kingdom
-
Astellas Pharma IncCompletedChronic Kidney Disease Patients on Hemodialysis With HyperphosphatemiaJapan
-
Astellas Pharma IncCompletedRenal Insufficiency | Chronic Kidney Disease | HyperphosphatemiaJapan
-
Astellas Pharma IncFibroGenCompleted
-
Astellas Pharma IncCompletedHealthy | Urine Phosphorus ExcretionJapan
-
Astellas Pharma IncActive, not recruiting
-
Astellas Pharma IncCompletedRenal Insufficiency | Chronic Kidney Disease | Hyperphosphatemia | Renal DialysisJapan
-
Astellas Pharma IncCompletedA Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal DialysisRenal Insufficiency | Chronic Kidney Disease | Renal DialysisJapan
-
Astellas Pharma Europe B.V.CompletedPharmacokinetics of ASP1707United Kingdom
-
Astellas Pharma IncCompletedA Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on DialysisRenal Insufficiency | Chronic Kidney Disease | HyperphosphatemiaJapan
-
Astellas Pharma IncCompletedHealthy VolunteersJapan
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLCRecruitingAdvanced Solid TumorsUnited States, Japan
-
Astellas Pharma IncImmunomic Therapeutics, Inc.Completed
-
Astellas Pharma IncCompletedChronic Renal Failure Patients With Hyperphosphataemia Receiving HemodialysisJapan
-
Astellas Pharma Global Development, Inc.CompletedTumors | Incurable Platinum Refractory Germ Cell TumorsUnited States
-
Astellas Pharma IncCompletedChronic Kidney DiseaseJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncFibroGenCompleted
-
Astellas Pharma Europe B.V.CompletedPharmacokinetics of ASP1707 | Pharmacodynamics of ASP1707France
-
Astellas Pharma IncImmunomic Therapeutics, Inc.Completed
-
Amal TherapeuticsBoehringer IngelheimRecruitingPancreatic Ductal AdenocarcinomaUnited States, Switzerland
-
Astellas Pharma IncFibroGenCompletedHemodialysis Chronic Kidney Disease Patients With AnemiaJapan
-
Astellas Pharma Europe B.V.FibroGenCompletedHepatic Insufficiency | Healthy Subjects | PK of FG-4592Bulgaria
-
Astellas Pharma Europe B.V.FibroGenCompletedHealthy Subjects | Pharmacokinetics of FG-4592Germany
-
Astellas Pharma Global Development, Inc.Kyowa Kirin Co., Ltd.CompletedHealthy Volunteers | Pharmacokinetics of ASKP1240United States
-
Astellas Pharma IncCompletedRenal Anemia Associated With Chronic Renal Failure (CRF)Japan
-
Astellas Pharma IncCompletedProstate CancerJapan
-
Astellas Pharma IncFibroGenCompletedChronic Kidney DiseaseJapan
-
Astellas Pharma Global Development, Inc.RecruitingChronic Kidney Disease | Renal AnemiaRomania, Spain, Belgium, Germany, Norway, Slovakia, Denmark, Czechia
-
Astellas Pharma Europe B.V.FibroGenCompletedHealthy Subjects | PK for FG-4592Germany
-
FibroGenAstraZeneca; Astellas Pharma IncTerminatedPrimary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)United States, Australia, Belgium, Germany, Israel, Italy, Korea, Republic of, Russian Federation, Spain, United Kingdom, France, Turkey, Canada, Denmark, India, Poland
-
Astellas Pharma IncCompletedA Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on HemodialysisChronic Kidney Disease | HyperphosphatemiaJapan
-
Astellas Pharma IncCompletedRenal Insufficiency | Chronic Kidney Disease | Renal DialysisJapan
-
FibroGenAstraZeneca; Astellas Pharma Europe B.V.CompletedAnemia in Incident Dialysis PatientsRussian Federation, Bulgaria, Thailand, United States, Argentina, Chile, Colombia, Korea, Republic of, Latvia, Malaysia, Mexico, Poland, Romania, Taiwan, Ukraine
-
Astellas Pharma Europe B.V.FibroGenCompletedAnemia in Chronic Kidney Disease in Non-dialysis PatientsSpain, Belarus, Bulgaria, Hungary, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom, Belgium, Georgia, Italy, Colombia, Dominican Republic, Estonia, Greece, Guatemala, Panama, Peru, South Africa, Turkey
-
FibroGenAstraZeneca; Astellas Pharma Europe B.V.CompletedCKD AnemiaUnited States, Australia, Thailand, Korea, Republic of, Malaysia, Mexico, Taiwan, New Zealand, Argentina, Chile, Colombia, Hong Kong, Peru, Philippines, Puerto Rico, Singapore
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of EnalaprilJapan